Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Neurological Disorder Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Neurological Disorder Drugsmarket, defines the market attractiveness level of Neurological Disorder Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Neurological Disorder Drugs industry, describes the types of Neurological Disorder Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neurological Disorder Drugs market and the development prospects and opportunities of Neurological Disorder Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neurological Disorder Drugs market in Chapter 13.
By Player:
Boehringer Ingelheim GmbH
AstraZeneca
Novartis AG
GlaxoSmithKline plc
Bayer AG
Merck & Co
Teva Pharmaceutical
By Type:
Antipsychotic
Hypnotic & Sedative
Analgesics
Anticoagulants
Others
By End-User:
Hospital
Clinic
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Neurological Disorder Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Neurological Disorder Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Neurological Disorder Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Neurological Disorder Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Neurological Disorder Drugs Market Analysis and Outlook to 2022
-
7.1 Global Neurological Disorder Drugs Consumption (2017-2022)
-
7.2 United States Neurological Disorder Drugs Consumption (2017-2022)
-
7.3 Europe Neurological Disorder Drugs Consumption (2017-2022)
-
7.4 China Neurological Disorder Drugs Consumption (2017-2022)
-
7.5 Japan Neurological Disorder Drugs Consumption (2017-2022)
-
7.6 India Neurological Disorder Drugs Consumption (2017-2022)
-
7.7 South Korea Neurological Disorder Drugs Consumption (2017-2022)
8 Region and Country-wise Neurological Disorder Drugs Market Analysis and Outlook to 2028
-
8.1 Global Neurological Disorder Drugs Consumption Forecast (2022-2028)
-
8.2 United States Neurological Disorder Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Neurological Disorder Drugs Consumption Forecast (2022-2028)
-
8.4 China Neurological Disorder Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Neurological Disorder Drugs Consumption Forecast (2022-2028)
-
8.6 India Neurological Disorder Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Neurological Disorder Drugs Consumption Forecast (2022-2028)
9 Global Neurological Disorder Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Neurological Disorder Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Antipsychotic Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Hypnotic & Sedative Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Analgesics Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Anticoagulants Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Neurological Disorder Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
10 Global Neurological Disorder Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Neurological Disorder Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Antipsychotic Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Hypnotic & Sedative Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Analgesics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Neurological Disorder Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
11 Global Neurological Disorder Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Neurological Disorder Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Neurological Disorder Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Neurological Disorder Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Neurological Disorder Drugs Market Competitive Analysis
-
14.1 Boehringer Ingelheim GmbH
-
14.1.1 Boehringer Ingelheim GmbH Company Details
-
14.1.2 Boehringer Ingelheim GmbH Neurological Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Boehringer Ingelheim GmbH Neurological Disorder Drugs Product and Service
-
14.2 AstraZeneca
-
14.2.1 AstraZeneca Company Details
-
14.2.2 AstraZeneca Neurological Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AstraZeneca Neurological Disorder Drugs Product and Service
-
14.3 Novartis AG
-
14.3.1 Novartis AG Company Details
-
14.3.2 Novartis AG Neurological Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis AG Neurological Disorder Drugs Product and Service
-
14.4 GlaxoSmithKline plc
-
14.4.1 GlaxoSmithKline plc Company Details
-
14.4.2 GlaxoSmithKline plc Neurological Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithKline plc Neurological Disorder Drugs Product and Service
-
14.5 Bayer AG
-
14.5.1 Bayer AG Company Details
-
14.5.2 Bayer AG Neurological Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bayer AG Neurological Disorder Drugs Product and Service
-
14.6 Merck & Co
-
14.6.1 Merck & Co Company Details
-
14.6.2 Merck & Co Neurological Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Merck & Co Neurological Disorder Drugs Product and Service
-
14.7 Teva Pharmaceutical
-
14.7.1 Teva Pharmaceutical Company Details
-
14.7.2 Teva Pharmaceutical Neurological Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Teva Pharmaceutical Neurological Disorder Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Neurological Disorder Drugs
-
Figure Neurological Disorder Drugs Picture
-
Table Global Neurological Disorder Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neurological Disorder Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neurological Disorder Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Neurological Disorder Drugs Consumption by Country (2017-2022)
-
Figure United States Neurological Disorder Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Neurological Disorder Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Neurological Disorder Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Neurological Disorder Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Neurological Disorder Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Neurological Disorder Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Neurological Disorder Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Neurological Disorder Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Neurological Disorder Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Neurological Disorder Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Neurological Disorder Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Neurological Disorder Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Neurological Disorder Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antipsychotic Consumption and Growth Rate (2017-2022)
-
Figure Global Hypnotic & Sedative Consumption and Growth Rate (2017-2022)
-
Figure Global Analgesics Consumption and Growth Rate (2017-2022)
-
Figure Global Anticoagulants Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Antipsychotic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hypnotic & Sedative Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Analgesics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anticoagulants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Neurological Disorder Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Neurological Disorder Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Boehringer Ingelheim GmbH (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Neurological Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Neurological Disorder Drugs Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Neurological Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Neurological Disorder Drugs Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Neurological Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Neurological Disorder Drugs Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Neurological Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Neurological Disorder Drugs Product and Service
-
Table Merck & Co (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Neurological Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Neurological Disorder Drugs Product and Service
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Neurological Disorder Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Neurological Disorder Drugs Product and Service
-
